- Home
- SKYE vs FBLG Comparison
SKYE vs FBLG Comparison
Compare SKYE & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- FBLG
- Stock Information
- Founded
- SKYE 2012
- FBLG 2021
- Country
- SKYE United States
- FBLG United States
- Employees
- SKYE N/A
- FBLG N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- SKYE Health Care
- FBLG
- Exchange
- SKYE Nasdaq
- FBLG NYSE
- Market Cap
- SKYE 172.9M
- FBLG 163.3M
- IPO Year
- SKYE N/A
- FBLG 2024
- Fundamental
- Price
- SKYE $6.35
- FBLG $3.42
- Analyst Decision
- SKYE Strong Buy
- FBLG Strong Buy
- Analyst Count
- SKYE 5
- FBLG 1
- Target Price
- SKYE $18.40
- FBLG $16.00
- AVG Volume (30 Days)
- SKYE 142.7K
- FBLG 743.9K
- Earning Date
- SKYE 08-09-2024
- FBLG 11-02-2024
- Dividend Yield
- SKYE N/A
- FBLG N/A
- EPS Growth
- SKYE N/A
- FBLG N/A
- EPS
- SKYE N/A
- FBLG N/A
- Revenue
- SKYE N/A
- FBLG N/A
- Revenue This Year
- SKYE N/A
- FBLG N/A
- Revenue Next Year
- SKYE N/A
- FBLG N/A
- P/E Ratio
- SKYE N/A
- FBLG N/A
- Revenue Growth
- SKYE N/A
- FBLG N/A
- 52 Week Low
- SKYE $1.44
- FBLG $1.08
- 52 Week High
- SKYE $19.41
- FBLG $46.00
- Technical
- Relative Strength Index (RSI)
- SKYE 53.72
- FBLG N/A
- Support Level
- SKYE $5.71
- FBLG N/A
- Resistance Level
- SKYE $6.69
- FBLG N/A
- Average True Range (ATR)
- SKYE 0.73
- FBLG 0.00
- MACD
- SKYE 0.12
- FBLG 0.00
- Stochastic Oscillator
- SKYE 57.33
- FBLG 0.00
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.